Literature DB >> 28146

Enzymatic basis for the Ca2+-induced cross-linking of membrane proteins in intact human erythrocytes.

G E Siefring, A B Apostol, P T Velasco, L Lorand.   

Abstract

The accumulation of Ca2+ ions in intact human erythrocytes leads to the production of membrane protein polymers larger than spectrin. The polymer has a heterogeneous size distribution and is rich in gamma-glutamyl-epsilon-lysine cross-links. Isolation of this isodipeptide, in amounts as high as 6 mol/10(5) g of protein, confirms the idea [Lorand L., Weissmann, L.B., Epel, D.L., and Bruner-Lorand, J. (1976), Proc. Natl. Acad. Sci. U.S.A. 73, 4479] that the Ca2+-induced membrane protein polymerization is mediated by transglutaminase. Formation of the polymer in the intact cells is inhibited by the addition of small, water-soluble primary amines. Inasmuch as these amines are known to prevent the Ca2+-dependent loss of deformability of the membrane, it is suggested that transglutaminase-catalyzed cross-linking may be a biochemical cause of irreversible membrane stiffening.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 28146     DOI: 10.1021/bi00606a022

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  37 in total

1.  Nucleotide binding by the erythrocyte transglutaminase/Gh protein, probed with fluorescent analogs of GTP and GDP.

Authors:  S N Murthy; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

2.  Inhibition of rat liver transglutaminase by nucleotides.

Authors:  S Kawashima
Journal:  Experientia       Date:  1991-07-15

3.  Ligand-induced conformational changes in tissue transglutaminase: Monte Carlo analysis of small-angle scattering data.

Authors:  P Mariani; F Carsughi; F Spinozzi; S Romanzetti; G Meier; R Casadio; C M Bergamini
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

4.  Reversible activation of cellular factor XIII by calcium.

Authors:  Gunhild Klarskov Kristiansen; Mette Dahl Andersen
Journal:  J Biol Chem       Date:  2011-01-18       Impact factor: 5.157

5.  Neurodegenerative diseases and transglutaminase.

Authors:  L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

6.  Method for screening and MALDI-TOF MS sequencing of encoded combinatorial libraries.

Authors:  Bi-Huang Hu; Marsha Ritter Jones; Phillip B Messersmith
Journal:  Anal Chem       Date:  2007-08-23       Impact factor: 6.986

7.  Increase in proliferative markers after inhibition of transglutaminase.

Authors:  P J Birckbichler; G R Orr; M K Patterson; E Conway; H A Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

8.  Cloning and expression of chicken erythrocyte transglutaminase.

Authors:  N Weraarchakul-Boonmark; J M Jeong; S N Murthy; J D Engel; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

9.  Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes.

Authors:  P Agre; D Virshup; V Bennett
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

10.  The inhibition of glucose-stimulated insulin secretion by primary amines. A role for transglutaminase in the secretory mechanism.

Authors:  P J Bungay; J M Potter; M Griffin
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.